Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL85606 (SB-277011) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
D2 receptor/Dopamine D2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416] | ||||||||
ChEMBL | Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis | B | 5.29 | pKi | 5160 | nM | Ki | J Med Chem (2017) 60: 1478-1494 [PMID:28186762] |
ChEMBL | Inhibition of [125I]iodosulpiride binding to human Dopamine D2L receptor expressed in CHO cells | B | 5.98 | pKi | 1050 | nM | Ki | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
ChEMBL | Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells | B | 6 | pKi | 1000 | nM | Ki | Bioorg Med Chem Lett (2001) 11: 685-688 [PMID:11266169] |
ChEMBL | Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells | B | 6 | pKi | 1000 | nM | Ki | Bioorg Med Chem Lett (2000) 10: 2553-2555 [PMID:11086728] |
ChEMBL | Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method | B | 6.3 | pKi | 501.19 | nM | Ki | Bioorg Med Chem (2016) 24: 1619-1636 [PMID:26951894] |
ChEMBL | Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis | B | 6.3 | pKi | 501.19 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 1329-1332 [PMID:26786693] |
ChEMBL | Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting | B | 6.31 | pKi | 489.78 | nM | Ki | J Med Chem (2016) 59: 8549-8576 [PMID:27564135] |
ChEMBL | Binding affinity to human DRD2 receptor by GTPgammaS binding assay | B | 6.4 | pKi | 398.11 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 5056-5059 [PMID:19635669] |
ChEMBL | Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay | F | 6.4 | pKi | 398.11 | nM | Ki | J Med Chem (2010) 53: 374-391 [PMID:19891474] |
ChEMBL | Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay | F | 6.4 | pKi | 398.11 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 908-912 [PMID:18178090] |
ChEMBL | Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins | F | 6.4 | pKi | 398.11 | nM | Ki | J Med Chem (2007) 50: 5076-5089 [PMID:17867665] |
ChEMBL | Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay | F | 6.4 | pKi | 398.11 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 901-907 [PMID:18248991] |
ChEMBL | Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay | F | 6.4 | pKi | 398.11 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 4799-4801 [PMID:19560918] |
D2 receptor/Dopamine D2 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL339] [GtoPdb: 215] [UniProtKB: P61169] | ||||||||
ChEMBL | Inhibition of [125I]iodosulpiride binding to rat Dopamine D2 receptor expressed in CHO cells | B | 5.55 | pKi | 2820 | nM | Ki | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
D3 receptor/Dopamine D3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462] | ||||||||
ChEMBL | Agonist activity at human dopamine D3 receptor expressed in CHO cells after 90 mins by [35S]-GTPgamma S assay | B | 5 | pKi | >10000 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 1329-1332 [PMID:26786693] |
ChEMBL | Inhibition of [125I]iodosulpiride binding to human Dopamine D3 receptor expressed in CHO cells | B | 7.95 | pKi | 11.2 | nM | Ki | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
ChEMBL | Displacement of [3H]N-methylspiperone from human D3 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis | B | 7.96 | pKi | 11 | nM | Ki | J Med Chem (2017) 60: 1478-1494 [PMID:28186762] |
GtoPdb | - | - | 8 | pKi | 10 | nM | Ki | J Pharmacol Exp Ther (2000) 294: 1154-65 [PMID:10945872] |
ChEMBL | Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells | B | 8 | pKi | 10 | nM | Ki | Bioorg Med Chem Lett (2001) 11: 685-688 [PMID:11266169] |
ChEMBL | Binding affinity towards human Dopamine receptor D3 by displacement of [125I]iodosulpiride expressed in CHO cells | B | 8 | pKi | 10 | nM | Ki | Bioorg Med Chem Lett (2000) 10: 2553-2555 [PMID:11086728] |
ChEMBL | Displacement of [3H]-spiperone from human dopamine D3 receptor expressed in CHO-K1 cell membranes after 90 mins by liquid scintillation counting | B | 8.19 | pKi | 6.46 | nM | Ki | J Med Chem (2016) 59: 8549-8576 [PMID:27564135] |
ChEMBL | Displacement of [3H]-spiperone from human dopamine D3 receptor expressed in CHO-K1 cell membranes after 90 mins by liquid scintillation counter method | B | 8.2 | pKi | 6.31 | nM | Ki | Bioorg Med Chem (2016) 24: 1619-1636 [PMID:26951894] |
ChEMBL | Binding affinity to human DRD3 receptor by GTPgammaS binding assay | B | 8.4 | pKi | 3.98 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 5056-5059 [PMID:19635669] |
ChEMBL | Antagonist activity at human Dopamine D3 receptor expressed in CHO cell by GTPgammaS binding assay | F | 8.4 | pKi | 3.98 | nM | Ki | J Med Chem (2010) 53: 374-391 [PMID:19891474] |
ChEMBL | Antagonist activity at human dopamine D3 receptor expressed in CHO cells after 90 mins by [35S]-GTPgamma S assay | B | 8.4 | pKi | 3.98 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 1329-1332 [PMID:26786693] |
ChEMBL | Antagonist activity at dopamine D3 receptor by GTPgammaS binding assay | F | 8.4 | pKi | 3.98 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 908-912 [PMID:18178090] |
ChEMBL | Antagonist activity at human dopamine D3 receptor by cell based GTPgammaS binding assay | F | 8.4 | pKi | 3.98 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 901-907 [PMID:18248991] |
ChEMBL | Displacement of [35S]GTP-gamma-S from human cloned dopamine D3 receptor expressed in CHO cells after 30 mins | F | 8.4 | pKi | 3.98 | nM | Ki | J Med Chem (2007) 50: 5076-5089 [PMID:17867665] |
ChEMBL | Antagonist activity at human D3 receptor expressed in CHO cells by [35S]GTPgammaS binding assay | F | 8.4 | pKi | 3.98 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 4799-4801 [PMID:19560918] |
D3 receptor/Dopamine D3 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3138] [GtoPdb: 216] [UniProtKB: P19020] | ||||||||
ChEMBL | Inhibition of [125I]-iodosulpiride binding to rat Dopamine D3 receptor expressed in CHO cells | B | 7.97 | pKi | 10.7 | nM | Ki | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
ChEMBL | Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D3 receptor after 45 mins by microplate scintillation counting analysis | B | 8.2 | pKi | 6.31 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 1329-1332 [PMID:26786693] |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay | B | 6.2 | pKi | 630.96 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 1329-1332 [PMID:26786693] |
ChEMBL | Displacement of [3H]dofetilide from hERG expressed in CHO cells | B | 5.7 | pIC50 | 1995.26 | nM | IC50 | J Med Chem (2007) 50: 5076-5089 [PMID:17867665] |
ChEMBL | Inhibition of human ERG | B | 5.7 | pIC50 | 1995.26 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 908-912 [PMID:18178090] |
ChEMBL | Displacement of [3H]Dofetilide from human ERG | B | 5.7 | pIC50 | 1995.26 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 901-907 [PMID:18248991] |
ChEMBL | Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay | B | 5.7 | pIC50 | 1995.26 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4799-4801 [PMID:19560918] |
ChEMBL | Displacement of [3H]dofetilide from human ERG | B | 5.7 | pIC50 | 1995.26 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5056-5059 [PMID:19635669] |
ChEMBL | Displacement of [3H]dofetidile from human ERG by scintillation proximity assay | B | 5.7 | pIC50 | 1995.26 | nM | IC50 | J Med Chem (2010) 53: 374-391 [PMID:19891474] |
ChEMBL | Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay | B | 6.17 | pIC50 | 676.08 | nM | IC50 | J Med Chem (2016) 59: 8549-8576 [PMID:27564135] |
ChEMBL | Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay | B | 6.2 | pIC50 | 630.96 | nM | IC50 | Bioorg Med Chem (2016) 24: 1619-1636 [PMID:26951894] |
H1 receptor/Histamine H1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL231] [GtoPdb: 262] [UniProtKB: P35367] | ||||||||
ChEMBL | Antagonist activity at histamine H1 receptor by FLIPR assay | F | 6.2 | pKi | 630.96 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 908-912 [PMID:18178090] |
ChEMBL | Antagonist activity at histamine H1 receptor by FLIPR assay | F | 6.2 | pKi | 630.96 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 901-907 [PMID:18248991] |
5-HT1D receptor in Human [GtoPdb: 3] [UniProtKB: P28221] | ||||||||
GtoPdb | - | - | 5.8 | pKi | - | - | - | J Pharmacol Exp Ther (2000) 294: 1154-65 [PMID:10945872] |
5-HT2B receptor in Human [GtoPdb: 7] [UniProtKB: P41595] | ||||||||
GtoPdb | - | - | 5.9 | pKi | - | - | - | J Pharmacol Exp Ther (2000) 294: 1154-65 [PMID:10945872] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]